Literature DB >> 12456493

Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries.

Jian-Yong Qian1, Akihiro Haruno, Yujiro Asada, Takahiro Nishida, Yasushi Saito, Takehisa Matsuda, Hikaru Ueno.   

Abstract

We previously observed that adenovirus-mediated expression of C-type natriuretic peptide (CNP) markedly inhibits neointima formation after balloon injury in rat carotid arteries, suggesting that CNP has multiple effects over its modest inhibitory effect on cellular proliferation. We hypothesized that local expression of CNP might have antithrombotic and antiinflammatory effects. Balloon-injured rabbit carotid arteries were infected with an adenovirus expressing human CNP (AdCNP), human tissue factor pathway inhibitor (AdTFPI), or bacterial beta-galactosidase (AdLacZ) or infused with saline. Seven days later, shear stress-induced thrombosis was evaluated by cyclic flow variation (CFV), reflecting recurrent cycles of thrombus formation and dislodgment. CFV was observed in all AdLacZ-infected and saline-infused arteries but not in arteries infected with AdCNP or AdTFPI even in the presence of epinephrine. Injury increased the expressions of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and infiltration of macrophages. However, these effects were markedly reduced in AdCNP-treated arteries but not in AdTFPI-infected ones. In AdCNP-infected arteries, injury-induced expression of inducible NO synthase (iNOS) was enhanced, leading to increased NO generation. Interestingly, when the enhanced NO production was inhibited, neither inhibitory effect was observed, and suppression of neointima formation by CNP was canceled. Our study demonstrates that overexpression of CNP shows antithrombotic and antiinflammatory effects and reduces neointima formation mainly through enhanced NO production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456493     DOI: 10.1161/01.res.0000043631.25915.e6

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout.

Authors:  Keven R Johnson; Todd M Hoagland; Kenneth R Olson
Journal:  J Exp Biol       Date:  2011-08-15       Impact factor: 3.312

Review 2.  Natriuretic peptides in cardiometabolic regulation and disease.

Authors:  Nora E Zois; Emil D Bartels; Ingrid Hunter; Birgitte S Kousholt; Lisbeth H Olsen; Jens P Goetze
Journal:  Nat Rev Cardiol       Date:  2014-05-13       Impact factor: 32.419

3.  Chronic treatment with C-type natriuretic peptide impacts differently in the aorta of normotensive and hypertensive rats.

Authors:  Carolina Caniffi; Flavia M Cerniello; Gonzalo Bouchet; María L Sueiro; Analía Tomat; Daniel González Maglio; Jorge E Toblli; Cristina Arranz
Journal:  Pflugers Arch       Date:  2019-06-11       Impact factor: 3.657

4.  C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.

Authors:  Ramona S Scotland; Marc Cohen; Paul Foster; Matthew Lovell; Anthony Mathur; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-22       Impact factor: 11.205

Review 5.  Novel vasodilators in heart failure.

Authors:  Payman Zamani; Barry H Greenberg
Journal:  Curr Heart Fail Rep       Date:  2013-03

6.  Differential effects of natriuretic peptides on arterial and venous coronary artery bypass conduits.

Authors:  Hao G Nguyen; Amit Korach; Chey Collura; Benjamin R Eskenazi; Joseph A Vita; Oz M Shapira
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

Review 7.  Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Authors:  Ines Pagel-Langenickel; Jens Buttgereit; Michael Bader; Thomas H Langenickel
Journal:  J Mol Med (Berl)       Date:  2007-04-12       Impact factor: 4.599

Review 8.  C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target.

Authors:  Natalie G Lumsden; Rayomand S Khambata; Adrian J Hobbs
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 9.  Systems biology and biomechanical model of heart failure.

Authors:  George E Louridas; Katerina G Lourida
Journal:  Curr Cardiol Rev       Date:  2012-08

10.  Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation.

Authors:  Ellen L Hughes; Patricia O Cover; Julia C Buckingham; Felicity N E Gavins
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.